9
Active INDs
4
Technology Platforms
600
Employees

Recent News

Athenex Appoints Teresa Bair, Esq. as Executive Officer and General Counsel

Athenex Announces $225 Million Loan Agreement with Oaktree

Athenex Oncology launches Facing MBC Together campaign to address isolation for people living with metastatic breast cancer

Other Highlights

Photography by Christopher Galluzzo / Nasdaq, Inc.

Photography by Christopher Galluzzo / Nasdaq, Inc.

On June 14, 2017, Athenex celebrated its initial public offering (IPO) at the Nasdaq MarketSite in Times Square.
At the 2019 San Antonio Breast Cancer Symposium, Athenex Oncology raised awareness of chemotherapy induced peripheral neuropathy. Visitors performed everyday tasks, while wearing experiential neuropathy gloves.
Athenex is building a 409,000 square foot manufacturing facility in Dunkirk, NY, with support from New York State.